223 related articles for article (PubMed ID: 17332059)
21. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Cancer Res; 2003 Sep; 63(18):5674-8. PubMed ID: 14522882
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
Kong G; Chua SS; Yijun Y; Kittrell F; Moraes RC; Medina D; Said TK
Oncogene; 2002 Oct; 21(47):7214-25. PubMed ID: 12370811
[TBL] [Abstract][Full Text] [Related]
23. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
24. Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors.
Shao R; Egecioglu E; Weijdegård B; Ljungström K; Ling C; Fernandez-Rodriguez J; Billig H
J Endocrinol; 2006 Sep; 190(3):857-70. PubMed ID: 17003286
[TBL] [Abstract][Full Text] [Related]
25. Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation.
Pham K; Dong J; Jiang X; Qu Y; Yu H; Yang Y; Olea W; Marini JC; Chan L; Wang J; Wehrens XH; Cui X; Li Y; Hadsell DL; Cheng N
Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E136-E149. PubMed ID: 27894063
[TBL] [Abstract][Full Text] [Related]
26. Keratin 6 is not essential for mammary gland development.
Grimm SL; Bu W; Longley MA; Roop DR; Li Y; Rosen JM
Breast Cancer Res; 2006; 8(3):R29. PubMed ID: 16790075
[TBL] [Abstract][Full Text] [Related]
27. Progestins and breast cancer.
Aupperlee M; Kariagina A; Osuch J; Haslam SZ
Breast Dis; 2005-2006; 24():37-57. PubMed ID: 16917138
[TBL] [Abstract][Full Text] [Related]
28. Regulation of hepatic progesterone and estrogen receptors in the female turtle, Chrysemys picta: relationship to vitellogenesis.
Custodia-Lora N; Novillo A; Callard IP
Gen Comp Endocrinol; 2004 Apr; 136(2):232-40. PubMed ID: 15028527
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands.
Carlini MJ; Recouvreux MS; Simian M; Nagai MA
BMC Cancer; 2018 Jun; 18(1):682. PubMed ID: 29940887
[TBL] [Abstract][Full Text] [Related]
30. Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis.
Bagheri-Yarmand R; Talukder AH; Wang RA; Vadlamudi RK; Kumar R
Development; 2004 Jul; 131(14):3469-79. PubMed ID: 15226262
[TBL] [Abstract][Full Text] [Related]
31. Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor.
Yazdani S; Kasajima A; Ogata H; Felizola SJ; Nakamura Y; Onodera Y; Watanabe M; Motoi F; Unno M; Sasano H
Neuroendocrinology; 2015; 101(4):309-20. PubMed ID: 25791399
[TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
Wang H; Lee EW; Zhou L; Leung PC; Ross DD; Unadkat JD; Mao Q
Mol Pharmacol; 2008 Mar; 73(3):845-54. PubMed ID: 18042733
[TBL] [Abstract][Full Text] [Related]
33. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
34. Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines.
Smid-Koopman E; Kuhne LC; Hanekamp EE; Gielen SC; De Ruiter PE; Grootegoed JA; Helmerhorst TJ; Burger CW; Brinkmann AO; Huikeshoven FJ; Blok LJ
J Soc Gynecol Investig; 2005 May; 12(4):285-92. PubMed ID: 15866122
[TBL] [Abstract][Full Text] [Related]
35. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
McGowan EM; Clarke CL
Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
[TBL] [Abstract][Full Text] [Related]
36. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.
Mote PA; Bartow S; Tran N; Clarke CL
Breast Cancer Res Treat; 2002 Mar; 72(2):163-72. PubMed ID: 12038707
[TBL] [Abstract][Full Text] [Related]
37. Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development.
Ramamoorthy S; Dhananjayan SC; Demayo FJ; Nawaz Z
Mol Endocrinol; 2010 Nov; 24(11):2099-113. PubMed ID: 20829392
[TBL] [Abstract][Full Text] [Related]
38. Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland.
Woodward TL; Mienaltowski AS; Modi RR; Bennett JM; Haslam SZ
Endocrinology; 2001 Jul; 142(7):3214-22. PubMed ID: 11416044
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase activity in the rat mammary gland during pregnancy, lactation, and weaning: a correlation with growth but not with progesterone receptor levels.
Sharoni Y; Feldman B; Teuerstein I; Levy J
Endocrinology; 1984 Nov; 115(5):1918-24. PubMed ID: 6092041
[TBL] [Abstract][Full Text] [Related]
40. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
